Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Nv v. Tolmar, Inc.

NOTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
JANSSEN PHARMACEUTICALS, INC., JANSSEN
PHARMACEUTICA NV,
Plaintiffs-Cross-Appellants
v.
TOLMAR, INC.,
Defendant-Appellant
______________________
2024-1699, 2024-1700, 2024-1980, 2024-2020
______________________
Appeals from the United States District Court for the
District of Delaware in No. 1:21-cv-01784-WCB-SRF, Cir-
cuit Judge William C. Bryson.
______________________
ON MOTION
______________________
Before LOURIE, TARANTO, and CHEN, Circuit Judges.
PER CURIAM.
O R D E R
Having “agreed to resolve all claims between them” in
this matter, ECF No. 34 at 7, the parties jointly move to
remand these appeals in light of the district court’s April 3,
2026 indicative ruling that it would vacate its March 13,
Case: 24-1699 Document: 36 Page: 1 Filed: 05/05/2026

-- 1 of 2 --

JANSSEN PHARMACEUTICALS, INC. v. TOLMAR, INC. 2
2024 final judgment and enter a consent judgment if this
court remanded.
This court takes no position on the propriety or neces-
sity of any vacatur, leaving it to the district court to con-
sider the principles enunciated in United States Bancorp
Mortgage Co. v. Bonner Mall Partnership, 513 U.S. 18, 29
(1994).
Accordingly,
IT IS ORDERED THAT:
(1) The motion is granted to the extent that the ap-
peals are remanded.
(2) Each side shall bear its own costs.
May 5, 2026
Date
FOR THE COURT
ISSUED AS A MANDATE: May 5, 2026
Case: 24-1699 Document: 36 Page: 2 Filed: 05/05/2026

-- 2 of 2 --